furosemide has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Advenier, C; Hirsch, A; Molimard, M; Naline, E | 1 |
| Bedouch, P; Bessard, G; Chavanon, O; Cracowski, JL; Devillier, P; Magne, JL; Stanke-Labesque, F | 1 |
2 other study(ies) available for furosemide and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
Furosemide inhibits bradykinin-induced contraction of human bronchi: role of thromboxane A2 receptor antagonism.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Aged; Animals; Binding, Competitive; Bradykinin; Bronchi; Furosemide; Humans; Kinetics; Male; Middle Aged; Muscle Contraction; Prostaglandin Endoperoxides, Synthetic; Receptors, Thromboxane; Theophylline; Thromboxane A2; Vasoconstrictor Agents | 1995 |
Furosemide inhibits thromboxane A2-induced contraction in isolated human internal mammary artery and saphenous vein.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Drug Interactions; Furosemide; Humans; In Vitro Techniques; Mammary Arteries; Saphenous Vein; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2000 |